FDA Again Hits AbbVie Parkinson’s Treatment With Complete Response Letter

FDA Again Hits AbbVie Parkinson’s Treatment With Complete Response Letter

Submitted by admin on June 25, 2024 - 11:29am
Source: 
BioSpace
News Tags: 
AbbVie
Parkinson's Disease
FDA
ABBV-951
Headline: 
FDA Again Hits AbbVie Parkinson’s Treatment With Complete Response Letter
snippet: 

The FDA has again denied AbbVie’s New Drug Application for its ABBV-951 Parkinson’s treatment due to issues with a third-party manufacturer. The pharma announced Tuesday that it received a Complete Response Letter from the regulator. 

Do Not Allow Advertisers to Use My Personal information